97 Cost-Benefit Analysis of Prevention of Neonatal Anemia With Recombinant Human Erythropoietin in Premature Infants

Pediatric Research - United States
doi 10.1203/00006450-200409000-00120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search